DocDollars

Spr Therapeutics, Inc

OH · United States · Reporting entity ID 100000151627

Total reported 2019–2025
$18.6M
#338 of 2,960 reporting companies — 0% of all reported industry payments
$5.82M in general payments across 33,014 records, plus $8.42M in research funding across 700 records.

How it breaks down

General payments $5,820,697
Research funding $8,417,466
Ownership & investment $4,364,615

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Spr Therapeutics, Inc reported $18.6M to US doctors and teaching hospitals from 2019 to 2025, ranking #338 of 2,960 reporting companies. 45% of that was research funding and 55% general payments such as consulting, speaking, food and travel. 33,014 general payment records and 700 research records were filed.

Common questions about Spr Therapeutics, Inc

How much has Spr Therapeutics, Inc paid US doctors?

Spr Therapeutics, Inc reported $18,602,778 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $5,820,697 in general payments, $8,417,466 in research funding and $4,364,615 in ownership and investment interests.

How does Spr Therapeutics, Inc rank among drug and device companies?

It ranks #338 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Spr Therapeutics, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.